Physician profile
Sandhya Chilukala
NPI 1619564705
$316.30
in general payments reported to CMS, 2019-2025
9 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.20 · 2023: $44.97 · 2024: $140 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $125.00 | 2024 | |
| Lilly USA, LLC | $46.43 | 2022-2023 | Trulicity, Baqsimi |
| Janssen Pharmaceuticals, INC | $34.45 | 2025 | Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $27.75 | 2025 | Austedo Xr, Uzedy |
| Ucb, INC. | $19.94 | 2025 | Nayzilam |
| Alkermes, INC. | $19.73 | 2025 | Aristada, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $15.26 | 2024 | Rexulti |
| Neurocrine Biosciences, INC. | $14.79 | 2022 | |
| Neurelis, INC. | $12.95 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandhya Chilukala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.